Polypid Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Polypid Ltd in the second quarter 2025?
Polypid Ltd achieved a return on average equity (ROE) of 108.94 % in its second quarter 2025, this is above PYPD's average return on equity of -182.7%.
Polypid Ltd shareholder's equity over the 12 months ending in its second quarter 2025 are valued at $12 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 185 other companies had a higher return on equity. While the total ranking for ROE unchanged, relative to the fourth quarter 2024 at no. 12.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2025) II. Quarter	(Dec 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter
Y / Y Equity Change	585.38 %	186.58 %	-	-7.94 %	-
Y / Y Net Income Change	-	397.21 %	-	-	-
Net Income (TTM) in Millions	13	23	0	39	45
Return On Equity (TTM)	108.94 %	242.79 %	-7.58 %	1091.11 %	1210.75 %
PYPD's Total Ranking	# 12	# 12	# 0	# 0	#
Equity (TTM) in Millions	11	20	8	8	2
Seq. Equity Change	-46.41 %	166.48 %	0 %	379.95 %	-77.59 %
Seq. Net Income Change	-	-	-	-	-

Back to PYPD Management Effectiveness >> PYPD's 5 Years Annual ROE >> Compare PYPD ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 186
Sector	# 828
Overall	# 12

Return On Equity Statistics
High	Average	Low
377.69 %	-182.7 %	-678.62 %
(Dec 31 2024)		(Dec 31 2022)

PYPD Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	11	8	-2	6	36
Y / Y Equity Change	42.8 %	-	-	-83.79 %	-50.59 %
Net Income in Millions	-34	29	24	-40	-43
Y / Y Net Income Change	-	20.59 %	-	-	-
Return On Equity	-311.39 %	377.69 %	-	-678.62 %	-118.47 %

Back to PYPD Management Effectiveness >> PYPD's 5 Years Annual ROE >> Compare PYPD ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PYPD's' Return on Equity at Yahoo Finance
PYPD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PYPD's Competitors
Subscribers only: Roe for Polypid Ltd's Suppliers
Subscribers only: Return On Equity for PYPD's Customers

Companies with similar Return On Equity at Jun 30 2025, within Healthcare Sector	ROE
Seres Therapeutics Inc	283.91 %
Capforce Inc	224.17 %
Champions Oncology Inc	191.98 %
Cytomx Therapeutics Inc	158.55 %
Abbvie Inc	140.20 %
Halozyme Therapeutics Inc	136.63 %
Organon and Co	125.00 %
Amgen Inc	97.92 %
3m Company	90.51 %
Eli Lilly And Company	87.91 %
Stablecoin Development Corporation	81.69 %
Earth Science Tech Inc	78.03 %
Abeona Therapeutics Inc	77.68 %
Biomx Inc	70.26 %
Medpace Holdings Inc	67.66 %
Dariohealth Corp	65.89 %
Medinotec Inc	65.57 %
Idexx Laboratories Inc	64.42 %
Exelixis Inc	63.47 %
Adma Biologics Inc	61.78 %
Nrc Health	61.35 %
Arcutis Biotherapeutics Inc	59.20 %
Illumina Inc	55.11 %
Puma Biotechnology Inc	53.09 %
Zoetis Inc	51.76 %
Concentra Group Holdings Parent Inc	50.78 %
Synlogic Inc	46.41 %
Entera Bio Ltd	46.01 %
Longduoduo Co Ltd	44.99 %
Agios Pharmaceuticals Inc	43.31 %

Date modified: 2026-07-07T12:42:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.